Do you prioritize adding a GLP-1 receptor agonist over an SGLT-2 inhibitor in patients with CKD related to type 2 diabetes, uncontrolled proteinuria despite being on an ACEi, and obesity?
1 Answers
Mednet Member
Nephrology · Penn Medicine Cherry Hill
My habit to date has been to use an SGLT-2 inhibitor first. I refer patients to PCPs or others for GLP-1 treatment for obesity, even if they have CKD.
